News from us and our partners

Tags

Topics

0 results

News
18 February, 2019
HOOKIPA Appoints Michael A. Kelly as Independent Director
News
12 February, 2019
AFYREN secures over 60 million euros of financing to move into its industrial development phase
News
31 January, 2019
Inotrem announces an extension of its license agreement for the biomarker soluble TREM-1 to cardiovascular diseases.
News
28 January, 2019
Avantium takes full ownership of Synvina
News
17 January, 2019
HighLife closes a €32 million round B financing
News
17 January, 2019
Asceneuron appoints Peter Van Vlasselaer as Chairman
News
11 January, 2019
Pixium Vision announces its wireless PRIMA chip successfully met the interim study endpoints for dry Age-related Macular Degeneration
News
2 January, 2019
Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead
News
17 December, 2018
ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10
News
13 December, 2018
Shockwave announces collaboration with Abiomed on physician training
News
13 December, 2018
Pixium Vision awarded Galien Prize 2018 for research with PRIMA system for dry AMD
News
13 December, 2018
Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding
News
21 November, 2018
HOOKIPA appoints Julie O'Neill as non-executive director
News
13 November, 2018
EryDel Appoints Stan Musial as Chief Financial Officer
News
16 October, 2018
EryDel Appoints Ronan W. Gannon as Chief Commercial Officer
News
8 October, 2018
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism

HOOKIPA Appoints Michael A. Kelly as Independent Director

AFYREN secures over 60 million euros of financing to move into its industrial development phase

Inotrem announces an extension of its license agreement for the biomarker soluble TREM-1 to cardiovascular diseases.

Avantium takes full ownership of Synvina

HighLife closes a €32 million round B financing

Asceneuron appoints Peter Van Vlasselaer as Chairman

Pixium Vision announces its wireless PRIMA chip successfully met the interim study endpoints for dry Age-related Macular Degeneration

Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead

ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10

Shockwave announces collaboration with Abiomed on physician training

Pixium Vision awarded Galien Prize 2018 for research with PRIMA system for dry AMD

Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding

HOOKIPA appoints Julie O'Neill as non-executive director

EryDel Appoints Stan Musial as Chief Financial Officer

EryDel Appoints Ronan W. Gannon as Chief Commercial Officer

New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism